ROTHBLATT MARTINE A sold UTHR
November 25, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 300 shares of United Therapeutics Corporation at $481.23 per share, a transaction worth $144.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$481.23
Total value
$144.4K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 25, 2025
Filing dateNovember 25, 2025
Shares owned after130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.